Advertisement
Screener

Bausch Health Companies Inc. (BHC) Other Comprehensive Income (Loss), Net of Tax

1.3 / 5 stars · 23/86 Roast Me

Bausch Health Companies Inc. Other Comprehensive Income (Loss), Net of Tax

Bausch Health Companies Inc. (BHC) reported Other Comprehensive Income (Loss), Net of Tax of -$16.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-30

  • Bausch Health Companies Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$16.00M, a 107.11% decline year-over-year.
  • Bausch Health Companies Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$44.00M, a 131.21% decline year-over-year.
  • Bausch Health Companies Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $40.00M.
  • Bausch Health Companies Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was -$10.00M, a 118.52% decline year-over-year.
  • Bausch Health Companies Inc. other comprehensive income (loss), net of tax for fiscal 2025 was $396.00M.
  • Bausch Health Companies Inc. other comprehensive income (loss), net of tax for fiscal 2024 was -$282.00M, a 265.88% decline from fiscal 2023.
  • Bausch Health Companies Inc. other comprehensive income (loss), net of tax for fiscal 2023 was $170.00M.
  • Bausch Health Companies Inc. other comprehensive income (loss), net of tax for fiscal 2022 was -$256.00M.
Period endOther Comprehensive Income (Loss), Net of Tax 3 monthOther Comprehensive Income (Loss), Net of Tax 3 month as first filedOther Comprehensive Income (Loss), Net of Tax 6 monthOther Comprehensive Income (Loss), Net of Tax 6 month as first filedOther Comprehensive Income (Loss), Net of Tax 9 monthOther Comprehensive Income (Loss), Net of Tax 9 month as first filedOther Comprehensive Income (Loss), Net of Tax 12 monthOther Comprehensive Income (Loss), Net of Tax 12 month as first filed
2026-06-30-$16.00M
10-Q · filed 2026-07-30
-$60.00M
10-Q · filed 2026-07-30
-$20.00M
derived: sum of 3 quarters · filed 2026-07-30
-$30.00M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31-$44.00M
10-Q · filed 2026-04-30
-$4.00M
derived: sum of 2 quarters · filed 2026-04-30
-$14.00M
derived: sum of 3 quarters · filed 2026-04-30
$211.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$40.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$30.00M
derived: sum of 2 quarters · filed 2026-02-19
$255.00M
derived: sum of 3 quarters · filed 2026-07-30
$396.00M
10-K · filed 2026-02-19
2025-09-30-$10.00M
10-Q · filed 2025-10-30
$215.00M
derived: sum of 2 quarters · filed 2026-07-30
$356.00M
10-Q · filed 2025-10-30
$138.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$225.00M
10-Q · filed 2026-07-30
$366.00M
10-Q · filed 2026-07-30
$148.00M
derived: sum of 3 quarters · filed 2026-07-30
$202.00M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$141.00M
10-Q · filed 2026-04-30
-$77.00M
derived: sum of 2 quarters · filed 2026-04-30
-$23.00M
derived: sum of 3 quarters · filed 2026-04-30
-$107.00M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31-$218.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
-$164.00M
derived: sum of 2 quarters · filed 2026-02-19
-$248.00M
derived: sum of 3 quarters · filed 2026-02-19
-$282.00M
10-K · filed 2026-02-19
2024-09-30$54.00M
10-Q · filed 2025-10-30
-$30.00M
derived: sum of 2 quarters · filed 2025-10-30
-$64.00M
10-Q · filed 2025-10-30
$108.00M
derived: sum of 4 quarters · filed 2026-02-19
2024-06-30-$84.00M
10-Q · filed 2025-07-31
-$118.00M
10-Q · filed 2025-07-31
$54.00M
derived: sum of 3 quarters · filed 2026-02-19
-$82.00M
derived: sum of 4 quarters · filed 2026-02-19
2024-03-31-$34.00M
10-Q · filed 2025-05-01
$138.00M
derived: sum of 2 quarters · filed 2026-02-19
$2.00M
derived: sum of 3 quarters · filed 2026-02-19
$71.00M
derived: sum of 4 quarters · filed 2026-02-19
2023-12-31$172.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
$36.00M
derived: sum of 2 quarters · filed 2026-02-19
$105.00M
derived: sum of 3 quarters · filed 2026-02-19
$170.00M
10-K · filed 2026-02-19
2023-09-30-$136.00M
10-Q · filed 2024-10-31
-$67.00M
derived: sum of 2 quarters · filed 2024-10-31
-$2.00M
10-Q · filed 2024-10-31
$201.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30$69.00M
10-Q · filed 2024-08-01
$134.00M
10-Q · filed 2024-08-01
$337.00M
derived: sum of 3 quarters · filed 2025-02-20
$93.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31$65.00M
10-Q · filed 2024-05-02
$268.00M
derived: sum of 2 quarters · filed 2025-02-20
$24.00M
derived: sum of 3 quarters · filed 2025-02-20
-$141.00M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31$203.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
-$41.00M
derived: sum of 2 quarters · filed 2025-02-20
-$206.00M
derived: sum of 3 quarters · filed 2025-02-20
-$256.00M
10-K · filed 2025-02-20
2022-09-30-$244.00M
10-Q · filed 2023-11-02
-$409.00M
derived: sum of 2 quarters · filed 2023-11-02
-$459.00M
10-Q · filed 2023-11-02
-$460.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30-$165.00M
10-Q · filed 2023-08-03
-$215.00M
10-Q · filed 2023-08-03
-$216.00M
derived: sum of 3 quarters · filed 2024-02-22
-$297.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31-$50.00M
10-Q · filed 2023-05-04
-$51.00M
derived: sum of 2 quarters · filed 2024-02-22
-$132.00M
derived: sum of 3 quarters · filed 2024-02-22
-$57.00M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$82.00M
derived: sum of 2 quarters · filed 2024-02-22
-$7.00M
derived: sum of 3 quarters · filed 2024-02-22
-$130.00M
10-K · filed 2024-02-22
2021-09-30-$81.00M
10-Q · filed 2022-11-03
-$6.00M
derived: sum of 2 quarters · filed 2022-11-03
-$129.00M
10-Q · filed 2022-11-03
-$54.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$75.00M
10-Q · filed 2022-08-09
-$48.00M
10-Q · filed 2022-08-09
$27.00M
derived: sum of 3 quarters · filed 2023-02-23
$46.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31-$123.00M
10-Q · filed 2022-05-10
-$48.00M
derived: sum of 2 quarters · filed 2023-02-23
-$29.00M
derived: sum of 3 quarters · filed 2023-02-23
$29.00M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$75.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$94.00M
derived: sum of 2 quarters · filed 2023-02-23
$152.00M
derived: sum of 3 quarters · filed 2023-02-23
-$45.00M
10-K · filed 2023-02-23
2020-09-30$19.00M
10-Q · filed 2021-11-02
$77.00M
derived: sum of 2 quarters · filed 2021-11-02
-$120.00M
10-Q · filed 2021-11-02
-$49.00M
derived: sum of 4 quarters · filed 2022-05-11
2020-06-30$58.00M
10-Q · filed 2021-08-03
-$139.00M
10-Q · filed 2021-08-03
-$68.00M
derived: sum of 3 quarters · filed 2022-05-11
-$165.00M
derived: sum of 4 quarters · filed 2022-05-11
2020-03-31-$197.00M
10-Q · filed 2021-05-04
-$126.00M
derived: sum of 2 quarters · filed 2022-05-11
-$223.00M
derived: sum of 3 quarters · filed 2022-05-11
-$168.00M
derived: sum of 4 quarters · filed 2022-05-11
2019-12-31$71.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11
-$26.00M
derived: sum of 2 quarters · filed 2022-05-11
$29.00M
derived: sum of 3 quarters · filed 2022-05-11
$50.00M
8-K · filed 2022-05-11
2019-09-30-$97.00M
10-Q · filed 2020-11-03
-$42.00M
derived: sum of 2 quarters · filed 2020-11-03
-$21.00M
10-Q · filed 2020-11-03
-$104.00M
derived: sum of 4 quarters · filed 2021-05-04
2019-06-30$55.00M
10-Q · filed 2020-08-06
$76.00M
10-Q · filed 2020-08-06
-$7.00M
derived: sum of 3 quarters · filed 2021-05-04
$5.00M
derived: sum of 4 quarters · filed 2021-05-04
2019-03-31$21.00M
10-Q · filed 2020-05-07
-$62.00M
derived: sum of 2 quarters · filed 2021-05-04
-$50.00M
derived: sum of 3 quarters · filed 2021-05-04
-$269.00M
derived: sum of 4 quarters · filed 2021-05-04
2018-12-31-$83.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04
-$71.00M
derived: sum of 2 quarters · filed 2021-05-04
-$290.00M
derived: sum of 3 quarters · filed 2021-05-04
-$244.00M
8-K · filed 2021-05-04
2018-09-30$12.00M
10-Q · filed 2019-11-04
-$207.00M
derived: sum of 2 quarters · filed 2019-11-04
-$161.00M
10-Q · filed 2019-11-04
-$167.00M
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30-$219.00M
10-Q · filed 2019-08-06
-$173.00M
10-Q · filed 2019-08-06
-$179.00M
derived: sum of 3 quarters · filed 2020-02-19
-$101.00M
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31$46.00M
10-Q · filed 2019-05-06
-$46.00M
10-Q · filed 2018-05-08
$40.00M
derived: sum of 2 quarters · filed 2020-02-19
$118.00M
derived: sum of 3 quarters · filed 2020-02-19
$174.00M
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31-$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$72.00M
derived: sum of 2 quarters · filed 2020-02-19
$128.00M
derived: sum of 3 quarters · filed 2020-02-19
$217.00M
10-K · filed 2020-02-19
2017-09-30$78.00M
10-Q · filed 2018-11-06
$134.00M
derived: sum of 2 quarters · filed 2018-11-06
$223.00M
10-Q · filed 2018-11-06
-$309.00M
derived: sum of 4 quarters · filed 2019-02-20
2017-06-30$56.00M
10-Q · filed 2018-08-07
$145.00M
10-Q · filed 2018-08-07
-$387.00M
derived: sum of 3 quarters · filed 2019-02-20
-$392.00M
derived: sum of 4 quarters · filed 2019-02-20
2017-03-31$89.00M
10-Q · filed 2018-05-08
-$443.00M
derived: sum of 2 quarters · filed 2019-02-20
-$448.00M
derived: sum of 3 quarters · filed 2019-02-20
-$545.00M
derived: sum of 4 quarters · filed 2019-02-20
2016-12-31-$532.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20
-$537.00M
derived: sum of 2 quarters · filed 2019-02-20
-$634.00M
derived: sum of 3 quarters · filed 2019-02-20
-$571.00M
10-K · filed 2019-02-20
2016-09-30-$5.00M
10-Q · filed 2017-11-07
-$5.40M
10-Q · filed 2016-11-09
-$102.00M
derived: sum of 2 quarters · filed 2017-11-07
-$39.00M
10-Q · filed 2017-11-07
-$39.10M
10-Q · filed 2016-11-09
-$119.30M
derived: sum of 4 quarters · filed 2018-08-10
2016-06-30-$97.00M
10-Q · filed 2017-08-08
-$34.00M
10-Q · filed 2017-08-08
-$33.70M
10-Q · filed 2016-08-09
-$114.30M
derived: sum of 3 quarters · filed 2018-08-10
-$288.00M
derived: sum of 4 quarters · filed 2018-08-10
2016-03-31$63.00M
10-Q · filed 2017-05-09
$63.50M
10-Q · filed 2016-06-07
-$17.30M
derived: sum of 2 quarters · filed 2018-08-10
-$191.00M
derived: sum of 3 quarters · filed 2018-08-10
-$155.10M
derived: sum of 4 quarters · filed 2018-08-10
2015-12-31-$80.30M
derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10
-$254.00M
derived: sum of 2 quarters · filed 2018-08-10
-$218.10M
derived: sum of 3 quarters · filed 2018-08-10
-$630.00M
8-K · filed 2018-08-10
-$629.50M
10-K · filed 2016-04-29
2015-09-30-$173.70M
10-Q · filed 2016-11-09
-$137.80M
derived: sum of 2 quarters · filed 2016-11-09
-$549.70M
10-Q · filed 2016-11-09
-$915.00M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$35.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$376.00M
10-Q · filed 2016-08-09
-$741.30M
derived: sum of 3 quarters · filed 2017-03-01
-$1.19B
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$411.90M
10-Q · filed 2016-06-07
-$777.20M
derived: sum of 2 quarters · filed 2017-03-01
-$1.22B
derived: sum of 3 quarters · filed 2017-03-01
-$1.19B
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$365.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$811.40M
derived: sum of 2 quarters · filed 2017-03-01
-$777.00M
derived: sum of 3 quarters · filed 2017-03-01
-$785.00M
10-K · filed 2017-03-01
-$784.70M
10-K · filed 2016-04-29
2014-09-30-$446.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-26
-$411.70M
derived: sum of 2 quarters · filed 2015-10-26
-$419.70M
10-Q · filed 2015-10-26
-$391.30M
derived: sum of 4 quarters · filed 2016-04-29
2014-06-30$34.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28
$26.40M
10-Q · filed 2015-07-28
$54.80M
derived: sum of 3 quarters · filed 2016-04-29
$237.80M
derived: sum of 4 quarters · filed 2016-04-29
2014-03-31-$8.00M
10-Q · filed 2015-04-30
$20.40M
derived: sum of 2 quarters · filed 2016-04-29
$203.40M
derived: sum of 3 quarters · filed 2016-04-29
$56.30M
derived: sum of 4 quarters · filed 2016-04-29
2013-12-31$28.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29
$211.40M
derived: sum of 2 quarters · filed 2016-04-29
$64.30M
derived: sum of 3 quarters · filed 2016-04-29
-$13.10M
10-K · filed 2016-04-29
2013-09-30$183.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24
$35.90M
derived: sum of 2 quarters · filed 2014-10-24
-$41.50M
10-Q · filed 2014-10-24
-$41.45M
10-Q · filed 2013-11-01
$12.42M
derived: sum of 4 quarters · filed 2014-10-24
2013-06-30-$147.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
-$224.50M
10-Q · filed 2014-08-01
-$224.50M
10-Q · filed 2013-08-07
-$170.58M
derived: sum of 3 quarters · filed 2014-08-01
-$56.00M
derived: sum of 4 quarters · filed 2014-08-01
2013-03-31-$77.40M
10-Q · filed 2014-05-09
-$77.40M
10-Q · filed 2013-05-03
-$23.48M
derived: sum of 2 quarters · filed 2014-05-09
$91.10M
derived: sum of 3 quarters · filed 2014-05-09
-$111.45M
derived: sum of 4 quarters · filed 2014-05-09
2012-12-31$53.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$168.50M
derived: sum of 2 quarters · filed 2013-11-01
-$34.05M
derived: sum of 3 quarters · filed 2013-11-01
$160.22M
10-K · filed 2013-02-28
2012-09-30$114.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01
-$87.97M
derived: sum of 2 quarters · filed 2013-11-01
$106.30M
10-Q · filed 2013-11-01
$82.59M
10-Q · filed 2012-11-05
$12.73M
derived: sum of 4 quarters · filed 2013-11-01
2012-06-30-$202.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
-$8.28M
10-Q · filed 2013-08-07
-$101.84M
derived: sum of 3 quarters · filed 2013-08-07
2012-03-31$194.28M
10-Q · filed 2013-05-03
$100.71M
derived: sum of 2 quarters · filed 2013-05-03
2011-12-31-$93.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
-$380.66M
10-K · filed 2013-02-28
2011-09-30-$287.09M
10-Q · filed 2012-11-05
2010-12-31$55.26M
10-K · filed 2013-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
UroGen Pharma Ltd. (URGN)$2.015B-18.42